193566 Issues in facility siting to create healthy high-performance schools

Tuesday, November 10, 2009: 8:50 AM

Ann M. Carroll, MPH , US EPA, Office of Brownfields and Land Revitalization, Washington DC, DC
In January 2008 the Energy Independence and Security Act (EISA) was signed into law. Section 461 amended the Toxic Substance Control Act creating a new Title V, Healthy High-Performance Schools. Section 502 of the new title directed EPA to develop voluntary school siting guidelines addressing potential site contamination, transportation to sites, energy efficiency and site use as an emergency shelter. We will outline these newly developed federal guidelines and discuss best practices identified in the course of their development. The relevance of the guidelines for public, private, tribal and charter schools will be addressed. In addition to the four focus areas delimited within the statute, the panel will highlight the implications for environmental justice, sustainable development, and smart growth and the built environment. Members of the panel will include representatives from the US EPA, The Center for Disease Control/Agency for Toxic Substances and Disease Registry, and state or local and community representatives.

Learning Objectives:
1. Describe the Energy Independence and Security Act of 2008 and explain new federal voluntary guidelines 2. Connect to existing state and local guidelines and practices 3. Identify additional financial and technical resources available to communities concerned about new or existing school sites.

Keywords: Child/Adolescent, Environmental Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have participated in the team that developed the guidelines that are the subject of this session and I am qualified to present content or moderate this panel.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.